Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

European patent broadly protects Pharming's transgenic cattle generation technology

Aug. 9, 1996

Sequana to acquire NemaPharm

Aug. 9, 1996

Guilford obtains exclusive rights to drug delivery technology

Aug. 9, 1996

Collaboration on production/delivery system of microbial antigens announced

Aug. 9, 1996

Merck discontinues screening agreement with Martek

Aug. 9, 1996

University of Colorado's ribozyme technology protected by Japanese patent

Aug. 9, 1996

Genomic map development accord signed

Aug. 9, 1996

SIBIA and Cognetix sign conopeptide research collaboration

Aug. 9, 1996

Enzon's SCA protein technology patent extended

July 26, 1996

Synsorb Biotech licenses technology for enteropathogenic E. coli infection treatment

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...